Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18840162 | 0.80 | — | — | |
| SCHEMBL8025929 | 0.75 | SMN1; SMN2 (0.51) | SMN1; SMN2 | |
| SCHEMBL9939750 | 0.68 | SMN1; SMN2 (0.57) | SMN1; SMN2 | |
| SCHEMBL9885529 | 0.65 | — | — | |
| SCHEMBL20246670 | 0.64 | NLRP3 (0.32) | GLA | |
| SCHEMBL18117000 | 0.62 | CA1 (0.32) | — | |
| SCHEMBL22283801 | 0.61 | GLA (0.32) | GLA | |
| SCHEMBL1568536 | 0.61 | — | — | |
| SCHEMBL5544959 | 0.61 | SMN1; SMN2 (0.65) | SMN1; SMN2 | |
| SCHEMBL18510166 | 0.60 | GLA (0.41) | GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10287419-B2 | Rubber composition and vulcanization aid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20170130028-A1 | RUBBER COMPOSITION AND VULCANIZATION AID | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170130028-A1 | RUBBER COMPOSITION AND VULCANIZATION AID | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-11 | — | — | US | disclosed |
| EP-3075777-A1 | RUBBER COMPOSITION AND VULCANIZATION AID | Sumitomo Chemical Company Limited (JP) | 2016-10-05 | — | — | EP | disclosed |
| EP-2035436-A1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB Pharma S.A. (BE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008001076-A1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB PHARMA S.A. (BE) | 2008-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10287419-B2 | Rubber composition and vulcanization aid | CCNA1, RCN1, RER1 | SMN1; SMN2 3110/4885GLA 897/4885 |
| US-20170130028-A1 | RUBBER COMPOSITION AND VULCANIZATION AID | CCNA1, RCN1, RER1 | SMN1; SMN2 3110/4885GLA 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.